Skip to content

Rigel Pharmaceuticals RIGL Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMED logo
CONMEDCNMD
$6.23M+6.4%
Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%

Segments

By segment

See full
Single reportable segment$3.35M

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×